Dow Surges 600 Points SP 500 and Nasdaq Rally as Oil Declines and Bond Yields Retreat Ahead of Nvidia Earnings TikTok Goes Dark in US Market Uncertainty Looms as Trump Signals Potential Intervention IRS Tax Refund Deadline Millions of Americans May Have Unclaimed COVIDEra Payments US Real GDP Growth Trends 19802031 Historical Performance and Forward Projections US Stock Futures and Bond Yields Decline as Putin Updates Nuclear Doctrine Ashiana Housing to Develop Premium Residential Project in Jaipur with Rs 560 Crore Investment SSM Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Disclosure CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge SPG Q1 2026 Earnings A Close EPS Miss Reflects Steady Operations Amid Cautious Market The RealReal REAL Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction Comstock Inc LODE Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Discipline DV Q1 2026 Earnings EPS Miss Weighs on Shares as Market Digests Profitability Pressure Functional Brands Inc MEHA Faces Sharp Decline Testing AllTime Lows Hilton Worldwide HLT Surges 35 as Hospitality Demand Strengthens Dare Bioscience DARE Edges Higher Amid Steady Support Levels DexCom DXCM Pulls Back 243 as Stock Approaches Key Support Level Rithm Property Trust RPT Slides 145 Approaches Critical Support Zone Iran Refuses to Bow as Trump Rejects Peace Offer Extending Middle East Tensions Implications for Oil Markets Atmos Energy Corporation ATO Q1 2026 Earnings EPS Surpasses Estimates Stock Inches Higher BRX Sees Marginal Decline as Brixmor Property Group Hovers Near Support Zone ISSC Q1 2026 Earnings Strong EPS Beat Amid Limited Revenue Disclosure FIZZ Q1 2026 Earnings EPS Falls Slightly Short Amid Cost Headwinds LMFA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Company Posts Zero Revenue OBK Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction PRCT Q1 2026 Earnings EPS Narrowly Beats Estimates as Stock Slips German American Bancorp Inc Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline